Suchergebnisse
10x Genomics (TXG) Upgraded to Buy: Here's Why
Investors might want to bet on 10x Genomics (TXG), as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one of
All You Need to Know About Hayward Holdings (HAYW) Rating Upgrade to Buy
Hayward Holdings, Inc. (HAYW) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates --
OPKO Health (OPK) Upgraded to Buy: Here's What You Should Know
OPKO Health (OPK) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one of the
AkzoNobel (AKZOY) Upgraded to Buy: Here's What You Should Know
Investors might want to bet on Akzo Nobel NV (AKZOY), as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting
All You Need to Know About Bandwidth (BAND) Rating Upgrade to Buy
Bandwidth (BAND) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting
All You Need to Know About First Business Financial Services (FBIZ) Rating Upgrade to Buy
First Business Financial Services (FBIZ) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings
Capital Bancorp (CBNK) Upgraded to Buy: Here's What You Should Know
Capital Bancorp (CBNK) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting
Quad/Graphics (QUAD) Upgraded to Strong Buy: Here's Why
Quad/Graphics (QUAD) could be a solid choice for investors given its recent upgrade to a Zacks Rank #1 (Strong Buy). An upward trend in earnings estimates -- one of the most powerful forces
What Makes Argenx (ARGX) a New Buy Stock
Investors might want to bet on argenex SE (ARGX), as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one
Palvella Therapeutics Q2 Earnings Call Highlights
Key Points
- Interested in Palvella Therapeutics, Inc.? Here are five stocks we like better.
- Palvella remains on track to submit its NDA for QTORIN rapamycin in microcystic lymphatic
People Incorporated Common Stock Q2 Earnings Call Highlights
Key Points
- Interested in People Incorporated Common Stock? Here are five stocks we like better.
- Digital performance improved: People Inc. digital revenue rose 6% year over year for its 11th
Otter Tail Q2 Earnings Call Highlights
Key Points
- Interested in Otter Tail Corporation? Here are five stocks we like better.
- Otter Tail raised its full-year adjusted EPS guidance to $5.68–$6.08, despite second-quarter adjusted EPS
New Mountain Finance Q2 Earnings Call Highlights
Key Points
- Interested in New Mountain Finance Corporation? Here are five stocks we like better.
- NMFC’s second-quarter adjusted net investment income was $0.26 per share, covering its $0.25
Will BOOT's Raised Fiscal 2027 Outlook Hold as Tariff Refunds Fade?
Boot Barn Holdings, Inc. BOOT raised its fiscal 2027 earnings outlook after a first-quarter beat, but the quality of that increase matters. Tariff refunds supplied a large, temporary margin lift
Value Line's 2026 Earnings Improve Y/Y on EAM Growth
Shares of Value Line, Inc. VALU have declined 0.6% since the company reported its earnings for the fiscal year ended April 30, 2026. This compares to the S&P 500 index’s 2.9% decline over the same
BTSG Raises 2026 Guidance as Specialty and Home Health Drive Growth
BrightSpring Health Services, Inc. BTSG exceeded second-quarter expectations and raised its 2026 outlook as pharmacy and provider operations expanded together. The results strengthened the case that
Is BTSG a Buy as Rapid Growth Collides With Its Premium Valuation?
BrightSpring Health Services, Inc. BTSG is pairing faster earnings growth with broader operating momentum, but the stock’s valuation already reflects high expectations. The company’s latest quarter
Gartner Q2 Earnings Beat Estimates, '26 EPS Outlook Raised
Gartner, Inc. IT reported better-than-expected second-quarter 2026 results, with both earnings and revenues surpassing the Zacks Consensus Estimate.
Adjusted earnings of $4.37 per share beat the
Should Investors Buy YUM Stock for Its $9B Digital Growth Engine?
Yum! Brands, Inc. YUM is building a digital ecosystem that spans ordering, loyalty and restaurant operations. Digital system sales excluding Pizza Hut approached $9 billion in the second quarter
Should You Buy, Sell or Hold MP Stock Before Q2 Earnings Release?
MP Materials MP is scheduled to announce its second-quarter 2026 results on Aug. 6, after market close.
The Zacks Consensus Estimate for MP’s second-quarter revenues is $99.2 million, indicating a